tiprankstipranks
Trending News
More News >
EMS-CHEMIE HOLDING AG (CH:EMSN)
:EMSN
Advertisement

EMS-CHEMIE HOLDING AG (EMSN) AI Stock Analysis

Compare
1 Followers

Top Page

CH:EMSN

EMS-CHEMIE HOLDING AG

(OTC:EMSN)

Rating:64Neutral
Price Target:
CHF656.00
▲(9.06% Upside)
EMS-CHEMIE HOLDING AG's overall stock score is primarily driven by its strong financial performance, characterized by solid profitability and a robust balance sheet. However, technical analysis indicates bearish momentum, and the valuation suggests the stock may be overvalued. The absence of earnings call data and corporate events limits additional insights.

EMS-CHEMIE HOLDING AG (EMSN) vs. iShares MSCI Switzerland ETF (EWL)

EMS-CHEMIE HOLDING AG Business Overview & Revenue Model

Company DescriptionEMS-CHEMIE HOLDING AG is a leading Swiss specialty chemicals company based in Domat/Ems, Switzerland. The company operates primarily in two segments: EMS-Product and EMS-Group. EMS-Product focuses on the development and production of high-performance polymers, while EMS-Group is involved in the manufacture of engineered and specialty plastics. Core products include polymer-based materials used in automotive, electrical, and consumer goods industries, which are known for their high quality and innovative applications.
How the Company Makes MoneyEMS-CHEMIE HOLDING AG generates revenue primarily through the sale of its high-performance polymers and specialty plastics to various industries, including automotive, electronics, and consumer goods. The company benefits from strong demand for lightweight and durable materials, especially in automotive applications, where there is a growing trend towards fuel efficiency and performance. Key revenue streams include direct sales to manufacturers and partnerships with global companies in the automotive and electronics sectors, allowing EMS to leverage its product innovations and expand its market reach. Additionally, the company invests in research and development to create advanced materials that meet evolving industry standards and customer needs, further enhancing its profitability.

EMS-CHEMIE HOLDING AG Financial Statement Overview

Summary
EMS-CHEMIE HOLDING AG demonstrates strong financial health with solid profitability and a robust balance sheet. Despite a slight decline in revenue and free cash flow, the company maintains strong margins and effective cash flow conversion. The low Debt-to-Equity Ratio and high ROE further highlight financial stability.
Income Statement
65
Positive
EMS-CHEMIE HOLDING AG demonstrates stable financial performance with respectable margins. The Gross Profit Margin for the latest year is approximately 46.86%, and the Net Profit Margin stands at 22.25%. However, the company experienced a revenue decline of 5.38% from the previous year, which impacts overall performance. EBIT and EBITDA margins are strong at 26.02% and 29.10%, respectively, indicating efficient cost management.
Balance Sheet
78
Positive
The balance sheet of EMS-CHEMIE HOLDING AG reflects financial stability with a low Debt-to-Equity Ratio of 0.005, suggesting minimal leverage and a strong equity position. The Return on Equity (ROE) is high at 25.11%, demonstrating effective utilization of shareholder funds. The Equity Ratio is robust at 82.39%, indicating a strong capital structure.
Cash Flow
72
Positive
Cash flow analysis shows a solid Free Cash Flow to Net Income Ratio of 0.97, demonstrating strong cash generation relative to net income. However, there is a decline in Free Cash Flow by 15.10% year-over-year, which could pose a concern if it continues. The Operating Cash Flow to Net Income Ratio is 1.04, indicating good cash flow conversion.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.00B2.07B2.19B2.44B2.25B1.80B
Gross Profit952.70M970.46M594.99M713.92M729.66M596.97M
EBITDA608.82M603.52M542.36M658.40M698.03M566.20M
Net Income461.84M460.79M457.58M532.10M550.32M434.34M
Balance Sheet
Total Assets2.48B2.23B2.17B2.32B2.32B2.08B
Cash, Cash Equivalents and Short-Term Investments613.49M519.54M465.24M380.55M137.40M161.79M
Total Debt24.77M8.78M32.34M13.52M19.41M22.43M
Total Liabilities375.50M362.50M398.56M471.61M496.35M453.29M
Stockholders Equity2.07B1.83B1.74B1.82B1.80B1.60B
Cash Flow
Free Cash Flow451.44M447.51M527.08M746.15M376.93M401.31M
Operating Cash Flow484.33M480.37M576.47M840.12M456.85M472.13M
Investing Cash Flow165.70M176.63M-146.93M-198.52M-99.25M-87.78M
Financing Cash Flow-388.47M-403.72M-451.24M-500.49M-405.48M-473.39M

EMS-CHEMIE HOLDING AG Technical Analysis

Technical Analysis Sentiment
Negative
Last Price601.50
Price Trends
50DMA
618.30
Negative
100DMA
604.15
Negative
200DMA
605.67
Negative
Market Momentum
MACD
-3.71
Positive
RSI
38.66
Neutral
STOCH
21.69
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:EMSN, the sentiment is Negative. The current price of 601.5 is below the 20-day moving average (MA) of 613.93, below the 50-day MA of 618.30, and below the 200-day MA of 605.67, indicating a bearish trend. The MACD of -3.71 indicates Positive momentum. The RSI at 38.66 is Neutral, neither overbought nor oversold. The STOCH value of 21.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CH:EMSN.

EMS-CHEMIE HOLDING AG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
CHF29.68B24.26
1.95%-1.05%
64
Neutral
CHF14.07B30.4622.08%2.87%-4.25%-0.03%
61
Neutral
$10.43B7.39-0.05%2.88%2.86%-36.73%
$3.34B23.605.38%5.52%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CH:EMSN
EMS-CHEMIE HOLDING AG
601.50
-65.44
-9.81%
CH:SIKA
Sika AG
184.95
-78.41
-29.77%
CLZNF
Clariant AG
9.34
-4.60
-33.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 11, 2025